国产av不卡一区二区_欧美xxxx做受欧美_成年人看的毛片_亚洲第一天堂在线观看_亚洲午夜精品久久久中文影院av_8x8ⅹ国产精品一区二区二区_久久精品国产sm调教网站演员_亚洲av综合色区无码一二三区_成人免费激情视频_国产九九九视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Q and A with CEO

Takeda CEO: Patients to benefit from innovation drive

By Zhou Wenting in Shanghai | China Daily | Updated: 2019-08-09 10:27
Share
Share - WeChat
The logo of Japanese Takeda Pharmaceutical Co is seen at an office building in Glattbrugg near Zurich, in this March 7, 2012 file photo. [Photo/Agencies]

Japanese biopharmaceutical company Takeda Pharmaceutical Co Ltd completed the purchase of Shire Plc in January, making rare diseases another key business area in addition to oncology, gastroenterology, and neuroscience among others in the company's global business blueprint.

In an interview with China Daily when participating in a summer camp in Shanghai for children suffering from rare diseases from all over the country last month, Chief Executive Officer Christophe Weber said the company plans to make significant investments over the next five years in research and development in China, focusing on unmet medical needs in the country.

The combination of China's continued healthcare reforms and the government's focus on encouraging innovation, along with the company's robust plan to accelerate innovation in the country, will result in the availability of 10 of Takeda's innovative medicines in the coming years, including three for patients suffering from rare diseases.

What's Takeda's next-step development goal in the area of rare diseases?

Rare diseases are now a strategic area for Takeda. It's an area where we invest a lot in our R&D based on the innovative pipeline already in place. We intend to launch and introduce new medicines for patients in China. Some are already available in the Chinese market, and we are accelerating the launch of some others.

Currently, we are preparing five new drug applications in this area in China. Next year, we are expecting the approval of three such products.

For example, one drug that had been approved in the United States and Europe is to treat hereditary angioedema, a severe genetic disease creating immune reactions. So far there is no innovative therapy available for this disease, only palliative treatment.

We're also expecting drugs for patients suffering from Fabry (a rare disorder that arises from a deficiency of a particular enzyme) and Gaucher disease (a rare genetic disorder that results in serious bone damage and even death).There is no innovative therapy to treat Fabry in China, and for Gaucher, there is one drug introduced more than a decade ago.

The country's regulators have streamlined and accelerated new drug approvals for those with urgent clinical demand or treating rare diseases. How do you interpret such changes and how will they have an effect on the future performance of Takeda?

I'm impressed by the tremendous developments in China regarding the registration of new drugs, which has become much faster. The drug approval process today compared to even three years ago, is completely different. For an R&D-driven company like us, we now have the opportunity to bring our innovative portfolio to China.

In the next few years, we're planning to launch 10 new medicines across our portfolio in China, and the number is larger than the sum of new products launched in the past 15 years. And this shows that the measures introduced by the Chinese authorities for medical supervision have been transformative.

Another example is that Takeda launched an innovative medicine for the treatment of multiple myeloma, a type of blood cancer, last year. It was brought forward from the original estimated time frame of the 2019 financial year. Takeda received regulatory approval for the new drug in April 2018, and made the product available to patients three months later, almost a whole year in advance.

In the past year the drug has been used to treat a large number of patients in China.

How would you describe China's position in Takeda's global blueprint?

China is strategic and important, and it's a key priority for Takeda for various reasons. One is that now there is a clear policy that we've witnessed in which China aims to provide innovative medicines to patients, and our focus is innovative medicines, and therefore there is good convergence.

Also, the country's medical market is huge based on its vast population.

And Takeda is a global biopharmaceutical company that originated in Asia, and Japan and China are neighbors. Actually, Takeda began as a family business in 1781, originally focusing on traditional Chinese medicine.

Is there any detailed plan to boost investment in the Chinese market?

Across the pharmaceutical value chain in the past financial year, Takeda added more than $100 million to its investment in China, which has taken the company's registered capital in the country to nearly $200 million.

We have been increasingly investing in clinical development programs; for example, we want the development of all our new products in China to be synchronized with the progress in other regions in the world. This means China needs to be involved at an early stage in the development of new medicines.

The Takeda Development Center in Shanghai was established in 2012 to speed up the company's clinical trial efforts in China and focus on the development of innovative medicines for China and Asia. In 2017, it was upgraded as the company's R&D center for Asia. It's a strategic R&D center and it requires spending. All the products we are launching right now in the market come from this willingness to invest more.

When we develop a new medicine, we make sure that the development is suitable for four main markets - China, the US, Europe and Japan. It illustrates how strategic China is for us.

In March, Takeda invested a further 110 million yuan ($16 million) in the expansion of its Tianjin facility, which functions as the manufacturing final step for the Chinese market.

Takeda has its roots in Asia. Do you think it has an advantage in the Chinese market compared to other pharmaceutical companies, most of which are from Europe and the United States?

Our advantage may include a good relationship between China and Japan in various aspects, and geographical and cultural proximity. I think in talent development, we also have an advantage in recruiting Chinese people to work or go on exchange programs in Japan.

The Takeda Science Foundation actively strengthens Sino-Japanese medical exchanges and promotes cross-border medical cooperation and development. For the best part of the past four decades, the foundation has wholly funded more than 260 Chinese physicians to fulfill medical educational programs in Japan.

Another small advantage is that it's a short flight for me to come from Japan. I come to China every year, and I'm coming more often, especially when the environment is pro-innovation and the opportunity for growth is stronger than ever before.

The country has its Healthy China 2030 strategy and Shanghai has its goal of becoming a medical center in Asia. How do you think such initiatives will influence the development of pharmaceutical companies in the country?

Such strong ambitions to be at the forefront of innovation are beneficial for a market of rising openness and will attract more investment from businesses that focus on innovative medicine R&D.

I think it's an exciting time for the healthcare industry and for companies like Takeda at the moment because China is now, more than ever before, willing to embrace new medicines. It also provides more hope to fight against health issues for patients and doctors.

In the area of new medicine development, we are already working with and are exploring collaborations with a rising number of local partners, including established research institutions and hospitals. I do see that the research capability in China is really progressive. We are monitoring the innovative climate as we are really keen to partner with local universities and biotech startups.

Do you remember your first visit to China? How was it different from this visit?

My first visit to China was in the early 1990s when the streets were filled with bicycles, which have been largely replaced by automobiles today. I witnessed the huge economic development of China as well as the healthcare sector. It's understandable that after a country's economic development reaches a certain level, the government and society will invest more in healthcare.

I was a junior member of staff when I first visited China - a product manager looking for opportunities for market development. Over the years, I have had more opportunities to talk to local hospitals, research institutions and government officials, and feel that they have thrived on professionalism.

As a professional in the health industry for decades, what is your health advice for young people and children?

Enough physical exercise, healthy diet and good sleep are always the golden rules, and now we need to add a moderate use of digital products. That's the typical advice we should give to kids and the younger generation. Everybody should manage technology instead of being managed by technology.

Young workers should also strike a balance between work and life. It's easy these days to lose the balance as people may stay on call around the clock or be dragged into unhealthy lifestyles. Every one should be responsible for his or her lifestyle.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
五月天亚洲婷婷| 日韩精品福利一区二区三区| 羞羞色国产精品| 日韩一区二区精品| 国产精品不卡视频| 美女精品一区二区| 99久久精品费精品国产风间由美| 日韩经典一区| 18视频免费网址在线观看| eeuss影院www| 日韩二区三区在线| 欧美性xxxx18| 国产精品毛片久久久久久久| 国产一区二区三区免费播放| 亚洲欧美综合久久久| 中文字幕av一区二区三区四区| 中文字幕在线观看播放| 操操操综合网| 柠檬福利视频导航| www.欧美免费| 欧美不卡视频一区| 日韩欧美在线第一页| 国产精品成人一区二区艾草| 国产精品天美传媒| 国产精品乱码一区二区三区软件| 国产精品嫩草影院com| 国产精品午夜电影| 亚洲人成精品久久久久| 99精品热视频| 久久99热狠狠色一区二区| 亚洲一级黄色| 精品午夜久久| 成人知道污网站| 欧美少妇激情| 人狥杂交一区欧美二区| 欧美另类极品| 色哟哟在线观看| av网站一区| 九九热在线观看| 国产卡一卡二卡三| 7777免费精品视频| 日韩视频在线一区| 欧美理论片在线观看| 中文字幕精品在线视频| 日韩精品999| 91精品国产综合久久婷婷香蕉 | 午夜性色一区二区三区免费视频| 天美av一区二区三区久久| 九九在线精品| 国产96在线亚洲| 久草成人在线| 欧美日韩免费| 蜜臀国产一区二区三区在线播放 | 欧美自拍丝袜亚洲| 亚洲国产sm捆绑调教视频| 中文字幕一区二区三区精华液| 91啦中文在线观看| 成人丝袜高跟foot| 国产成人aaa| 国产在线播精品第三| eeuss国产一区二区三区 | 伊人成人开心激情综合网| 日韩av中文字幕在线免费观看| 国产视频精品xxxx| 欧美日韩aaaa| 久久亚洲精品成人| 色偷偷偷综合中文字幕;dd| 亚洲欧美日韩成人| 国产丝袜视频一区| 久久艹在线视频| 久久伊人精品天天| 亚洲一道本在线| 992tv成人免费影院| 九色国产视频| 高清视频国产| 日本肉体xxxx裸体784大胆| avtt天堂资源网站| 免费人成黄页在线观看忧物| 麻豆影视在线| 成年午夜在线| 国产在线二区| av软件在线观看| 成人黄色在线| 爱情电影网av一区二区| 精品国产一区二区三区2021| 国模大尺度视频一区二区| 最新国产精品视频| 1024精品一区二区三区| 一本色道久久精品| 首页国产欧美日韩丝袜| 视频一区国产视频| caoporn国产一区二区| 一区二区三区四区乱视频| 亚洲一区二区三区四区的 | 亚洲综合在线免费观看| 欧美日本乱大交xxxxx| 日韩中文字幕91| 国产91高潮流白浆在线麻豆| 中文字幕亚洲一区二区va在线| 色婷婷综合五月| 91成人看片片| 91精品综合久久久久久| 日韩欧美一级在线播放| 亚洲精品久久久久久久久久久久久| 欧美大尺度在线观看| 国产在线精选视频| 福利视频网址导航| 欧美色图另类| 日韩成人影音| 欧美欧美在线| 综合国产视频| 石原莉奈在线亚洲三区| 久久久99久久| 亚洲综合激情另类小说区| 666欧美在线视频| 久热在线中文字幕色999舞| 国产成人的电影在线观看| 免费观看v片在线观看| 国产精品视频一区二区久久| av色综合久久天堂av色综合在| 在线高清欧美| 天堂一区二区三区四区| 国产精品久久久久久模特| 看国产成人h片视频| 亚洲欧美自拍偷拍| 日韩免费视频一区二区| 538国产精品一区二区在线| 国产黄色一级片| 亚州av电影免费在线观看| av色综合久久天堂av色综合在| 麻豆视频久久| 99在线精品视频在线观看| 久久久久久久综合日本| 91精选在线观看| 97免费视频在线播放| 国产网站av| 又爽又大又黄a级毛片在线视频| 51漫画成人app入口| 成人精品国产亚洲| 欧美午夜国产| 国产一区美女在线| 精品国产精品三级精品av网址| 亚洲人成网7777777国产| 国产一卡2卡3卡4卡网站免费| 精品一区精品二区| 欧美电影在线观看免费| 一二三四视频在线中文| 欧美黄视频在线观看| 亚洲一级二级| 国产精品人妖ts系列视频| 欧美一级搡bbbb搡bbbb| 激情综合丝袜美女一区二区| 中文日本高清免费| jvid一区二区三区| 亚洲经典三级| 亚洲视频一区在线观看| 亚洲欧美日韩视频一区| 羞羞影视羞羞在线| 中文在线a在线| 国产乱码在线| 成人污污视频| 亚洲中字黄色| 97精品国产97久久久久久久久久久久| 欧美在线你懂得| 国语自产精品视频在线看抢先版图片| 美女av网站| 最新国产在线拍揄自揄视频| 亚欧日韩另类中文欧美| 久久激情网站| 91麻豆精品视频| 日韩视频一区二区| 欧美虐宫另类残忍视频| 特黄特黄的视频| 欧美6一10sex性hd| 97一区二区国产好的精华液| 欧美片第1页综合| 欧美国产国产综合| 欧美日韩精品二区第二页| 这里只有视频精品| 9l视频自拍蝌蚪9l视频| 色资源二区在线视频| 国产在线日韩| 亚洲综合在线观看视频| 俺去了亚洲欧美日韩| 国产超级av| 成人黄色网址| 九九热播视频在线精品6| 久久不射中文字幕| 亚洲高清在线视频| 欧美—级a级欧美特级ar全黄| 给个网站可以在线观看你懂的| 忘忧草在线日韩www影院| 亚洲一级影院| 亚洲高清在线精品| 韩国欧美亚洲国产| 国产青青草在线| 精品大片一区二区| 久久久久久久久久看片| 亚洲欧美日韩国产成人| 久草香蕉在线| а√天堂资源官网在线资源| 精品在线99| 操人视频91| 国产国语**毛片高清视频| 日本欧美不卡| 日韩精品一区第一页| 日本高清不卡在线观看| 最近中文字幕在线6| 国产精品福利电影一区二区三区四区| 精品视频在线视频| 久久亚洲国产精品成人av秋霞| 快色在线观看| 视频一区日韩精品| 成人午夜激情片| 亚洲精品久久久久中文字幕二区 | 亚洲国产毛片完整版| 男人的天堂色| 922tv免费观看在线| 北条麻妃在线一区二区免费播放 | 美女网站在线看| 欧美亚洲免费| 欧美日本在线视频| 青青青草视频| 国产精品美女午夜爽爽| 欧美午夜视频| 亚洲福利视频三区| 九九久久久2| av在线不卡免费| 美女写真久久影院| 免费看男男www网站入口在线| 日韩精品一区二区三区中文| 99久久99久久久精品齐齐| 亚洲欧洲一区二区三区久久| 日本最黄视频| 国产欧美日韩一区二区三区四区| 激情丁香综合五月| 一本久道久久综合中文字幕 | 香蕉久久免费电影| 欧美日韩中文| 欧美性xxxx在线播放| 欧美性另类69xxxx| 小草在线视频免费播放| 免费观看久久久4p| 精品国产乱码久久久久久闺蜜| 欧美一级淫片a免费视频| 91老司机福利在线| 久久99精品国产麻豆婷婷| 精品99999| 日本中文字幕电影| 日韩av二区| 国产精品天天摸av网| 欧美成人一二三| 黄黄的网站在线观看| 国产亚洲亚洲| 日韩精品自拍偷拍| 嫩草嫩草嫩草| 日韩av大片| 日韩欧美在线看| 美女视频黄的免费| 亚洲欧洲成视频免费观看| 波多野结衣视频在线播放| 国产99在线观看| 美女视频一区在线观看| 日韩av中文字幕在线播放| 在线视频中文字幕| 中文字幕免费一区二区| 欧美国产视频在线| 久久久久久久久久久91| 青草影视电视剧免费播放在线观看| 日韩精品成人一区二区三区| 欧美精品一区二区三区在线| 成年免费视频| 偷拍精品福利视频导航| 一区二区三区欧美日韩| 精品视频二区三区| 成人黄色91| 中文一区一区三区高中清不卡| 性欧美办公室18xxxxhd| 欧美伦理91| 99久久国产综合精品女不卡| 欧美夫妻性视频| 123区在线| 成人av资源在线| 亚洲国产三级网| 丝袜视频国产在线播放| 伊人激情综合| 日韩精品一区二区三区在线播放| 濑亚美莉一二区在线视频 | 一区二区亚洲精品| 精品国产伦一区二区三区免费| 日本h片在线看| 天天久久夜夜| 性做久久久久久免费观看| 中文字幕av中文字幕| 成人精品国产亚洲| 国产精品色一区二区三区| 色综合久久五月天| mm视频在线视频| 无遮挡的视频在线观看| 日韩精品国产精品| 亚洲色图日韩av| 国产黄网站在线观看| 韩国欧美国产1区| 欧美成人精品在线观看| 欧美巨猛xxxx猛交黑人97人| 97视频在线观看成人| 欧美男男tv网站在线播放| 99精品黄色片免费大全| 日本综合一区二区三区| 亚洲伊人精品酒店| 一区二区三区资源| 久久久久女教师免费一区| 老司机精品视频在线观看6| 老司机一区二区| 久热99视频在线观看| 六月婷婷综合| 亚洲欧美在线另类| 美女大黄三级视频在线观看| 俺要去色综合狠狠| 亚洲电影第三页| 拍拍拍999自拍偷| 加勒比中文字幕精品| 亚洲福利视频导航| 97影院理论片在线播放| 亚洲午夜电影| 伊人久久久久久久久久| av免费不卡国产观看| 久久久综合九色合综国产精品| 桃花网日韩影视在线观看视频| 欧美极度另类| 国产精品国模大尺度视频| 99久久精品一区二区三区| 美女毛片一区二区三区四区| 欧美天堂一区二区三区| 中文在线天堂网| 另类小说欧美激情| 欧美精品福利在线| 福利一区三区| 精品久久久久久久久久久久久| 国产不卡一卡2卡三卡4卡5卡在线| 怕怕欧美视频免费大全| 91精品欧美综合在线观看最新| 国产一区二区影视| 国产成人免费视频| 日韩欧美在线视频一区二区| 婷婷成人影院| 日韩一级片网址| 美女av在线播放| 91麻豆国产精品久久| 蜜桃91在线| 亚洲v在线看| 制服丝袜亚洲网站| av在线二区| www.欧美亚洲| 国产hs免费高清在线观看| 亚洲啊v在线观看| 国产亚洲福利一区| 黄色成人在线观看| 久久婷婷久久一区二区三区| 亚洲爱爱天堂| 欧洲在线一区| 日韩欧美国产三级| 尤物yw193can在线观看| 国产福利电影一区二区三区| 欧美成人性色生活仑片| 白嫩亚洲一区二区三区| 在线观看91视频| 成人高潮成人免费观看| 99在线视频精品| 青青艹在线视频| 亚洲激情午夜| 欧美激情视频给我| 免费成人蒂法| 精品国产免费久久| 久草在线中文最新视频| 亚洲自拍欧美精品| 性视频一区二区三区| 波多野结衣一区二区三区| 涩涩视频网站| 亚洲欧美网站| 久色婷婷小香蕉久久| 日韩禁在线播放| 欧美三级精品| 色猫猫国产区一区二在线视频| 国产视频二区在线观看| 91网站视频在线观看| www.夜夜骑.com| 日本伊人色综合网| 日韩亚洲成人av在线| 成人亚洲精品| 欧美精品日韩一区| 日本大片在线播放| 一区二区三区蜜桃网| 伊人网站在线| 91色在线porny| 夜色av.com| 国模一区二区三区| 欧美成人精品影院| 香蕉久久夜色精品国产更新时间 | 韩日精品中文字幕|